Gut microbiota-derived imidazole propionate predicts cardiometabolic risk in patients with coronary artery disease. Wenzl FA, Wang P, Kahles F, Beck KR, et al. Eur Heart J 2025 Aug 30:ehaf661. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wenzl FA, Wang P, Kahles F, Beck KR, et al. Gut microbiota-derived imidazole propionate predicts cardiometabolic risk in patients with coronary artery disease. Eur Heart J 2025 Aug 30:ehaf661. doi: 10.1093.
PMID: 40884168